2019 annual financial data
X4 Pharmaceuticals 2019 Operating margin
X4 Pharmaceuticals 2019 operating margin with verified reported values.
Direct answer
Operating margin was -1,560.1%.
Operating income was -46,803,000 USD and net income was -52,807,000 USD.
Operating cash flow was -48,055,000 USD.
Get free X4 Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,000,000 USD
- Operating income
- -46,803,000 USD
- Net income
- -52,807,000 USD
- Operating cash flow
- -48,055,000 USD